135 Publications (Page 1 of 6)
2020
Impact of Genetic Ancestry on Treatment Toxicity and Racial Disparities in Breast Cancer
Ballinger, Tarah JBallinger, Tarah JCunningham, Geneva MCunningham, Geneva MWu, XiWu, XiSchneider, Bryan P and Schneider, Bryan P
Current Breast Cancer Reports, 2020-05-12. | Journal Article
 
Precision Prevention: The Current State and Future of Genomically Guided Cancer Prevention
Kassem, NawalKassem, NawalStout, Leigh AnneStout, Leigh AnneHunter, CynthiaHunter, CynthiaSchneider, BryanSchneider, BryanRadovich, Milan and Radovich, Milan
JCO Precision Oncology, (no. 4), pp. 108, 2020-02-00. | Journal Article
 
Relations of Mindfulness and Illness Acceptance With Psychosocial Functioning in Patients With Metastatic Breast Cancer and Caregivers.
Chinh, KellySecinti, EkinJohns, Shelley AHirsh, Adam TMiller, Kathy DSchneider, BryanStorniolo, Anna MariaMina, LidaNewton, Erin VChampion, Victoria L and Mosher, Catherine E
Oncology nursing forum, vol. 47, (no. 6), pp. 739-752, November 1, 2020. | Journal Article
2019
Analytical Validation of Variants to Aid in Genotype-Guided Therapy for Oncology
Swart, MarelizeSwart, MarelizeSwart, MarelizeSwart, MarelizeStansberry, Wesley MStansberry, Wesley MStansberry, Wesley MStansberry, Wesley MPratt, Victoria MPratt, Victoria MPratt, Victoria MPratt, Victoria MMedeiros, Elizabeth BMedeiros, Elizabeth BMedeiros, Elizabeth BMedeiros, Elizabeth BKiel, Patrick JKiel, Patrick JKiel, Patrick JKiel, Patrick JShen, FeiShen, FeiShen, FeiShen, FeiSchneider, Bryan PSchneider, Bryan PSchneider, Bryan PSchneider, Bryan PSkaar, Todd CSkaar, Todd CSkaar, Todd C and Skaar, Todd C
The Journal of Molecular Diagnostics, vol. 21, (no. 3), pp. 502, May 2019. | Journal Article
 
Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis
Saad, Everardo DSquifflet, PierreBurzykowski, TomaszQuinaux, EmmanuelDelaloge, SuzetteMavroudis, DimitrisPerez, EdithPiccart-Gebhart, MartineSchneider, Bryan PSlamon, DennisWolmark, Norman and Buyse, Marc
The Lancet Oncology, vol. 20, (no. 3), pp. 370, March 2019. | Journal Article
 
Implications of incidental germline findings identified in the context of clinical whole exome sequencing (WES) for guiding cancer therapy
Schneider, Bryan PSchneider, Bryan PSchneider, Bryan PStout, Leigh AnneStout, Leigh AnneStout, Leigh AnnePhilips, SantoshPhilips, SantoshPhilips, SantoshHunter, CynthiaHunter, CynthiaHunter, CynthiaKiel, PatrickKiel, PatrickKiel, PatrickRadovich, MilanRadovich, Milan and Radovich, Milan
Journal of Clinical Oncology, vol. 37, (no. 15_suppl), pp. 1581, 2019-05-20. | Journal Article
 
Microsatellite Instability May Predict Response to Sipuleucel-T in Patients With Prostate Cancer
Zhang, Kevin JuanSchneider, Bryan Paul and Albany, Costantine
Clinical Genitourinary Cancer, vol. 17, (no. 3), pp. 239, June 2019. | Journal Article
 
Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers
Hancock, Bradley AHancock, Bradley AHancock, Bradley AHancock, Bradley AHancock, Bradley AHancock, Bradley AChen, Yu-HsiangChen, Yu-HsiangChen, Yu-HsiangChen, Yu-HsiangChen, Yu-HsiangChen, Yu-HsiangSolzak, Jeffrey PSolzak, Jeffrey PSolzak, Jeffrey PSolzak, Jeffrey PSolzak, Jeffrey PSolzak, Jeffrey PAhmad, Mufti NAhmad, Mufti NAhmad, Mufti NAhmad, Mufti NAhmad, Mufti NAhmad, Mufti NWedge, David CWedge, David CWedge, David CWedge, David CWedge, David CWedge, David CBrinza, DumitruBrinza, DumitruBrinza, DumitruBrinza, DumitruBrinza, DumitruBrinza, DumitruScafe, CharlesScafe, CharlesScafe, CharlesScafe, CharlesScafe, CharlesScafe, CharlesVeitch, JamesVeitch, JamesVeitch, JamesVeitch, JamesVeitch, JamesVeitch, JamesGottimukkala, RajeshGottimukkala, RajeshGottimukkala, RajeshGottimukkala, RajeshGottimukkala, RajeshGottimukkala, RajeshShort, WaltShort, WaltShort, WaltShort, WaltShort, WaltShort, WaltAtale, Rutuja VAtale, Rutuja VAtale, Rutuja VAtale, Rutuja VAtale, Rutuja VAtale, Rutuja VIvan, MirceaIvan, MirceaIvan, MirceaIvan, MirceaIvan, MirceaIvan, MirceaBadve, Sunil SBadve, Sunil SBadve, Sunil SBadve, Sunil SBadve, Sunil SBadve, Sunil SSchneider, Bryan PSchneider, Bryan PSchneider, Bryan PSchneider, Bryan PSchneider, Bryan PSchneider, Bryan PLu, XiongbinLu, XiongbinLu, XiongbinLu, XiongbinLu, XiongbinLu, XiongbinMiller, Kathy DMiller, Kathy DMiller, Kathy DMiller, Kathy DMiller, Kathy DMiller, Kathy DRadovich, MilanRadovich, MilanRadovich, MilanRadovich, MilanRadovich, Milan and Radovich, Milan
Breast cancer research : BCR, vol. 21, (no. 1), pp. 87, 2019-08-05. | Journal Article
 
Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
Tolaney, Sara MGuo, HaoPernas, SoniaBarry, William TDillon, Deborah ARitterhouse, LaurenSchneider, Bryan PShen, FeiFuhrman, KitBaltay, MicheleDang, Chau TYardley, Denise AMoy, BeverlyMarcom, P KellyAlbain, Kathy SRugo, Hope SEllis, Mathew JShapira, IulianaWolff, Antonio CCarey, Lisa AOvermoyer, BethPartridge, Ann HHudis, Clifford AKrop, Ian EBurstein, Harold J and Winer, Eric P
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 37, (no. 22), pp. 1875, 2019-08-01. | Journal Article
2018
Abstract 3882: Functional validation of a genome-wide association study (GWAS) SNP associated with anthracycline-induced congestive heart failure
Wu, XiWu, XiXue, GloriaXue, GloriaGardner, LauraGardner, LauraShen, FeiShen, FeiJiang, GuanglongJiang, GuanglongPhilips, SantoshPhilips, SantoshCunningham, GenevaCunningham, GenevaSchneider, Bryan P and Schneider, Bryan P
Cancer Research, vol. 78, (no. 13 Supplement), pp. 3882, 2018-07-01. | Journal Article
 
Acceptance and commitment therapy for symptom interference in metastatic breast cancer patients: a pilot randomized trial
Mosher, CatherineMosher, CatherineMosher, CatherineMosher, CatherineMosher, CatherineMosher, CatherineMosher, CatherineMosher, CatherineMosher, CatherineSecinti, EkinSecinti, EkinSecinti, EkinSecinti, EkinSecinti, EkinSecinti, EkinSecinti, EkinSecinti, EkinSecinti, EkinLi, RuohongLi, RuohongLi, RuohongLi, RuohongLi, RuohongLi, RuohongLi, RuohongLi, RuohongLi, RuohongHirsh, AdamHirsh, AdamHirsh, AdamHirsh, AdamHirsh, AdamHirsh, AdamHirsh, AdamHirsh, AdamHirsh, AdamBricker, JonathanBricker, JonathanBricker, JonathanBricker, JonathanBricker, JonathanBricker, JonathanBricker, JonathanBricker, JonathanBricker, JonathanMiller, KathyMiller, KathyMiller, KathyMiller, KathyMiller, KathyMiller, KathyMiller, KathyMiller, KathyMiller, KathySchneider, BryanSchneider, BryanSchneider, BryanSchneider, BryanSchneider, BryanSchneider, BryanSchneider, BryanSchneider, BryanSchneider, BryanStorniolo, AnnaStorniolo, AnnaStorniolo, AnnaStorniolo, AnnaStorniolo, AnnaStorniolo, AnnaStorniolo, AnnaStorniolo, AnnaStorniolo, AnnaMina, LidaMina, LidaMina, LidaMina, LidaMina, LidaMina, LidaMina, LidaMina, LidaMina, LidaNewton, ErinNewton, ErinNewton, ErinNewton, ErinNewton, ErinNewton, ErinNewton, ErinNewton, ErinNewton, ErinChampion, VictoriaChampion, VictoriaChampion, VictoriaChampion, VictoriaChampion, VictoriaChampion, VictoriaChampion, VictoriaChampion, VictoriaChampion, VictoriaJohns, ShelleyJohns, ShelleyJohns, ShelleyJohns, ShelleyJohns, ShelleyJohns, ShelleyJohns, ShelleyJohns, Shelley and Johns, Shelley
Supportive Care in Cancer, vol. 26, (no. 6), pp. 2004, 20180600. | Journal Article
 
A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer.
Diamond, Jennifer RDiamond, Jennifer RDiamond, Jennifer REckhardt, S GEckhardt, S GEckhardt, S GPitts, Todd MPitts, Todd MPitts, Todd Mvan Bokhoven, Adrievan Bokhoven, AdrieAisner, DaraAisner, DaraAisner, DaraGustafson, Daniel LGustafson, Daniel LGustafson, Daniel LCapasso, AnnaCapasso, AnnaCapasso, AnnaSams, SharonSams, SharonSams, SharonKabos, PeterKabos, PeterKabos, PeterZolman, KathrynZolman, KathrynZolman, KathrynColvin, TiffanyColvin, TiffanyColvin, TiffanyElias, Anthony DElias, Anthony DElias, Anthony DStorniolo, Anna MStorniolo, Anna MStorniolo, Anna MSchneider, Bryan PSchneider, Bryan PSchneider, Bryan PGao, DexiangGao, DexiangGao, DexiangTentler, John JTentler, John JTentler, John JBorges, Virginia FBorges, Virginia FMiller, Kathy D and Miller, Kathy D
Breast cancer research : BCR, vol. 20, (no. 1), pp. 82, August 2, 2018. | Journal Article
 
Efficacy of Different Leuprolide Administration Schedules in Premenopausal Breast Cancer: A Retrospective Review
Kendzierski, Daniel CSchneider, Bryan P and Kiel, Patrick J
Clinical Breast Cancer, vol. 18, (no. 5), pp. e942, October 2018. | Journal Article
 
Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II.
Li, YujingLi, YujingLi, YujingLi, YujingLi, YujingLi, YujingLi, YujingLiu, YunhuaLiu, YunhuaLiu, YunhuaLiu, YunhuaLiu, YunhuaLiu, YunhuaLiu, YunhuaXu, HanchenXu, HanchenXu, HanchenXu, HanchenXu, HanchenXu, HanchenXu, HanchenJiang, GuanglongJiang, GuanglongJiang, GuanglongJiang, GuanglongJiang, GuanglongJiang, GuanglongJiang, GuanglongVan der Jeught, KevinVan der Jeught, KevinVan der Jeught, KevinVan der Jeught, KevinVan der Jeught, KevinVan der Jeught, KevinVan der Jeught, KevinFang, YuanzhangFang, YuanzhangFang, YuanzhangFang, YuanzhangFang, YuanzhangFang, YuanzhangFang, YuanzhangZhou, ZhuolongZhou, ZhuolongZhou, ZhuolongZhou, ZhuolongZhou, ZhuolongZhou, ZhuolongZhou, ZhuolongZhang, LuZhang, LuZhang, LuZhang, LuZhang, LuZhang, LuZhang, LuFrieden, MichaelFrieden, MichaelFrieden, MichaelFrieden, MichaelFrieden, MichaelFrieden, MichaelFrieden, MichaelWang, LifeiWang, LifeiWang, LifeiWang, LifeiWang, LifeiWang, LifeiWang, LifeiLuo, ZhenhuaLuo, ZhenhuaLuo, ZhenhuaLuo, ZhenhuaLuo, ZhenhuaLuo, ZhenhuaLuo, ZhenhuaRadovich, MilanRadovich, MilanRadovich, MilanRadovich, MilanRadovich, MilanRadovich, MilanRadovich, MilanSchneider, Bryan PSchneider, Bryan PSchneider, Bryan PSchneider, Bryan PSchneider, Bryan PSchneider, Bryan PSchneider, Bryan PDeng, YibinDeng, YibinDeng, YibinDeng, YibinDeng, YibinDeng, YibinDeng, YibinLiu, YunlongLiu, YunlongLiu, YunlongLiu, YunlongLiu, YunlongLiu, YunlongLiu, YunlongHuang, KunHuang, KunHuang, KunHuang, KunHuang, KunHuang, KunHuang, KunHe, BinHe, BinHe, BinHe, BinHe, BinHe, BinHe, BinWang, JinWang, JinWang, JinWang, JinWang, JinWang, JinWang, JinHe, XiaomingHe, XiaomingHe, XiaomingHe, XiaomingHe, XiaomingHe, XiaomingHe, XiaomingZhang, XinnaZhang, XinnaZhang, XinnaZhang, XinnaZhang, XinnaZhang, XinnaZhang, XinnaJi, GuangJi, GuangJi, GuangJi, GuangJi, GuangJi, GuangJi, GuangLu, XiongbinLu, XiongbinLu, XiongbinLu, XiongbinLu, XiongbinLu, Xiongbin and Lu, Xiongbin
Nature communications, vol. 9, (no. 1), pp. 4394, October 22, 2018. | Journal Article
 
Identification of a Genomic Region Between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance).
Li, MeganLi, M.Li, MeganMulkey, FloraMulkey, FloraMulkey, F.Jiang, ChenJiang, ChenJiang, C.O'Neil, Bert HO'Neill, Bert HO’Neil, B.H.Schneider, Bryan PSchneider, B.P.Schneider, Bryan PShen, FeiShen, FeiShen, F.Friedman, Paula NFriedman, Paula NFriedman, P.N.Momozawa, YukihideMomozawa, Y.Momozawa, YukihideKubo, M.Kubo, MichiakiKubo, MichiakiNiedzwiecki, DonnaNiedzwiecki, D.Niedzwiecki, DonnaHochster, H.S.Hochster, Howard SHochster, Howard SLenz, H.-J.Lenz, Heinz-JosefLenz, Heinz-JosefAtkins, James NAtkins, James NAtkins, J.N.Rugo, Hope SRugo, Hope SRugo, H.S.Halabi, SusanHalabi, S.Halabi, SusanKelly, William KKelly, W.K.Kelly, William KevinMcLeod, H.L.McLeod, Howard LMc Leod, Howard LInnocenti, F.Innocenti, FedericoInnocenti, FedericoRatain, Mark JRatain, Mark JRatain, M.J.Venook, AlanVenook, Alan PVenook, A.P.Owzar, K.Owzar, KourosOwzar, KourosKroetz, Deanna LKroetz, Deanna and Kroetz, D.L.
Clinical cancer research : an official journal of the American Association for Cancer Research, June 5, 2018. | Journal Article
 
Identification of risk factors for toxicity in patients with hormone receptor-positive advanced breast cancer treated with bevacizumab plus letrozole: a CALGB 40503 (alliance) correlative study
Li, DanengLi, DanengLi, DanengLi, DanengLi, DanengMcCall, LindaMcCall, Linda MMcCall, Linda MMcCall, Linda MMcCall, LindaHahn, Olwen MHahn, OlwenHahn, OlwenHahn, Olwen MHahn, Olwen MHudis, CliffordHudis, CliffordHudis, Clifford AHudis, Clifford AHudis, Clifford ACohen, HarveyCohen, Harvey JCohen, Harvey JCohen, HarveyCohen, Harvey JMuss, HymanMuss, Hyman BMuss, HymanMuss, Hyman BMuss, Hyman BJatoi, AminahJatoi, AminahJatoi, AminahJatoi, AminahJatoi, AminahLafky, JacquelineLafky, Jacqueline MLafky, JacquelineLafky, Jacqueline MLafky, Jacqueline MBallman, Karla VBallman, Karla VBallman, KarlaBallman, Karla VBallman, KarlaWiner, Eric PWiner, EricWiner, EricWiner, Eric PWiner, Eric PTripathy, DebuTripathy, DebuTripathy, DebuTripathy, DebuTripathy, DebuSchneider, BryanSchneider, BryanSchneider, BryanSchneider, BryanSchneider, BryanBarry, WilliamBarry, WilliamBarry, WilliamBarry, WilliamBarry, WilliamDickler, Maura NDickler, Maura NDickler, MauraDickler, Maura NDickler, MauraHurria, ArtiHurria, ArtiHurria, ArtiHurria, Arti and Hurria, Arti
Breast Cancer Research and Treatment, vol. 171, (no. 2), pp. 334, 20180900. | Journal Article
 
Metastatic breast cancer patients’ expectations and priorities for symptom improvement
Tometich, Danielle BTometich, Danielle BTometich, Danielle BTometich, Danielle BTometich, DanielleTometich, Danielle BTometich, Danielle BTometich, Danielle BTometich, D.B.Tometich, Danielle BMosher, Catherine EMosher, Catherine EMosher, Catherine EMosher, Catherine EMosher, Catherine EMosher, Catherine EMosher, CatherineMosher, Catherine EMosher, Catherine EMosher, C.E.Hirsh, AdamHirsh, Adam THirsh, A.T.Hirsh, Adam THirsh, Adam THirsh, Adam THirsh, Adam THirsh, Adam THirsh, Adam THirsh, Adam TRand, Kevin LRand, Kevin LRand, Kevin LRand, KevinRand, K.L.Rand, Kevin LRand, Kevin LRand, Kevin LRand, Kevin LRand, Kevin LJohns, Shelley AJohns, Shelley AJohns, Shelley AJohns, Shelley AJohns, ShelleyJohns, Shelley AJohns, Shelley AJohns, Shelley AJohns, S.A.Johns, Shelley AMatthias, M.S.Matthias, Marianne SMatthias, Marianne SMatthias, Marianne SMatthias, Marianne SMatthias, MarianneMatthias, Marianne SMatthias, Marianne SMatthias, Marianne SMatthias, Marianne SOutcalt, Samantha DOutcalt, SamanthaOutcalt, Samantha DOutcalt, Samantha DOutcalt, S.D.Outcalt, Samantha DOutcalt, Samantha DOutcalt, Samantha DOutcalt, Samantha DOutcalt, Samantha DSchneider, B.P.Schneider, Bryan PSchneider, Bryan PSchneider, Bryan PSchneider, Bryan PSchneider, Bryan PSchneider, Bryan PSchneider, Bryan PSchneider, BryanSchneider, Bryan PMina, LidaMina, LidaMina, L.Mina, LidaMina, LidaMina, LidaMina, LidaMina, LidaMina, LidaMina, LidaStorniolo, Anna Maria VStorniolo, Anna Maria VStorniolo, Anna Maria VStorniolo, A.M.V.Storniolo, Anna Maria VStorniolo, Anna Maria VStorniolo, AnnaStorniolo, Anna Maria VStorniolo, Anna Maria VStorniolo, Anna Maria VNewton, E.V.Newton, Erin VNewton, Erin VNewton, Erin VNewton, Erin VNewton, Erin VNewton, Erin VNewton, Erin VNewton, Erin VNewton, ErinMiller, Kathy DMiller, Kathy DMiller, Kathy DMiller, K.D.Miller, Kathy DMiller, Kathy DMiller, Kathy DMiller, KathyMiller, Kathy D and Miller, Kathy D
Supportive Care in Cancer, pp. 1-8, May 2018. | Journal Article
 
Phase II Study of Maintenance Pembrolizumab in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC)
Gadgeel, Shirish MPennell, Nathan AFidler, Mary JoHalmos, BalazsBonomi, PhilipStevenson, JamesSchneider, BryanSukari, AmmarVentimiglia, JaclynChen, WeiGalasso, CathyWozniak, AntoinetteBoerner, Julie and Kalemkerian, Gregory P
Journal of Thoracic Oncology, vol. 13, (no. 9), pp. 1399, September 2018. | Journal Article
 
Somatic mutation of the cohesin complex subunit confers therapeutic vulnerabilities in cancer
Liu, YunhuaLiu, YunhuaLiu, YunhuaLiu, YunhuaLiu, YunhuaLiu, YunhuaXu, HanchenXu, HanchenXu, HanchenXu, HanchenXu, HanchenXu, HanchenVan der Jeught, KevinVanderJeught, KevinVan der Jeught, KevinVanderJeught, KevinVan der Jeught, KevinVanderJeught, KevinLi, YujingLi, YujingLi, YujingLi, YujingLi, YujingLi, YujingLiu, ShengLiu, ShengLiu, ShengLiu, ShengLiu, ShengLiu, ShengZhang, LuZhang, LuZhang, LuZhang, LuZhang, LuZhang, LuFang, YuanzhangFang, YuanzhangFang, YuanzhangFang, YuanzhangFang, YuanzhangFang, YuanzhangZhang, XinnaZhang, XinnaZhang, XinnaZhang, XinnaZhang, XinnaZhang, XinnaRadovich, MilanRadovich, MilanRadovich, MilanRadovich, MilanRadovich, MilanRadovich, MilanSchneider, Bryan PSchneider, Bryan PSchneider, Bryan PSchneider, Bryan PSchneider, Bryan PSchneider, Bryan PHe, XiaomingHe, XiaomingHe, XiaomingHe, XiaomingHe, XiaomingHe, XiaomingHuang, ChengHuang, ChengHuang, ChengHuang, ChengHuang, ChengHuang, ChengZhang, ChiZhang, ChiZhang, ChiZhang, ChiZhang, ChiZhang, ChiWan, JunWan, JunWan, JunWan, JunWan, JunWan, JunJi, GuangJi, GuangJi, GuangJi, GuangJi, GuangJi, GuangLu, XiongbinLu, XiongbinLu, XiongbinLu, XiongbinLu, Xiongbin and Lu, Xiongbin
Journal of Clinical Investigation, vol. 128, (no. 7), pp. 2951-2965, Jul 2018. | Journal Article
 
Sustained Exceptional Response to Poly (ADP-Ribose) Polymerase Inhibition Plus Temozolomide in Metastatic Melanoma With DNA Repair Deficiency
Kiel, Patrick JKiel, Patrick JKiel, Patrick JRadovich, MilanRadovich, MilanRadovich, MilanSchneider, Bryan PSchneider, Bryan PSchneider, Bryan PLogan, Theodore FLogan, Theodore F and Logan, Theodore F
JCO Precision Oncology, (no. 2), pp. 7, 2018-11-00. | Journal Article
 
Symptom burden and employment status in breast cancer (BC) survivors
Luis, Ines Maria Vaz DuarteLuis, Ines Maria Vaz DuarteO'Neill, Anne MO'Neill, Anne MSepucha, KarenSepucha, KarenMiller, Kathy DMiller, Kathy DDang, Chau TDang, Chau TNorthfelt, Donald WNorthfelt, Donald WWiner, Eric PWiner, Eric PSledge, George WSledge, George WSchneider, Bryan PSchneider, Bryan PPartridge, Ann and Partridge, Ann
Journal of Clinical Oncology, vol. 36, (no. 15_suppl), pp. 10073, 2018-05-20. | Journal Article
 
Urgent hypertension as a biomarker for bevacizumab in the curative setting
Kassem, NawalShen, FeiJiang, GuanglongGardner, LauraPhilips, SantoshO'Neill, Anne MMiller, Kathy DSuter, ThomasCameron, David ASledge, George W and Schneider, Bryan Paul
Journal of Clinical Oncology, vol. 36, (no. 15_suppl), pp. 548, 2018-05-20. | Journal Article
2017
Abstract 2029: Precision therapeutic combinations are synergistic against triple negative breast cancer using compensatory pathways
Solzak, Jeffrey PSolzak, Jeffrey PSolzak, Jeffrey PHancock, BradHancock, BradHancock, BradPaul, RobinPaul, RobinPaul, RobinKiel, PatrickKiel, PatrickKiel, PatrickSkaar, ToddSkaar, ToddSkaar, ToddSchneider, BryanSchneider, BryanSchneider, BryanRadovich, MilanRadovich, Milan and Radovich, Milan
Cancer Research, vol. 77, (no. 13 Supplement), pp. 2029, 2017-07-01. | Journal Article
 
Abstract 5401: Assessment of whole genome amplification for whole exome sequencing in detecting genetic mutation
Xue, CrystalGardner, LauraJiang, GuanglongShen, Fei and Schneider, Bryan
Cancer Research, vol. 77, (no. 13 Supplement), pp. 5401, 2017-07-01. | Journal Article
 
Abstract IA09: Impact of genetically determined race on outcomes in E5103
Schneider, Bryan Paul
Cancer Epidemiology Biomarkers & Prevention, vol. 26, (no. 2 Supplement), pp. IA09, 2017-02-00. | Journal Article